Final answer:
Glandular cell abnormalities are classified under the Bethesda system. The classifications include atypical glandular cells of undetermined significance (AGUS), adenocarcinoma in situ (AIS), low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance (ASCUS), squamous cell carcinoma (SCC), and low-grade squamous intraepithelial lesion (LSIL), adenocarcinoma in situ (AIS).
Step-by-step explanation:
The classifications of glandular cell abnormalities under the Bethesda system include:
- Atypical glandular cells of undetermined significance (AGUS), adenocarcinoma in situ (AIS)
- Low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL)
- Atypical squamous cells of undetermined significance (ASCUS), squamous cell carcinoma (SCC)
- Low-grade squamous intraepithelial lesion (LSIL), adenocarcinoma in situ (AIS)
These classifications help in identifying and diagnosing abnormalities in glandular cells, which are cells that line the glands in our body. Each classification represents a different level of abnormality, ranging from undetermined significance to pre-cancerous and cancerous conditions.